Actinogen Medical 's market cap is currently $119.77M. The company's EPS TTM is $-0.00133457; its P/E ratio is -12.50; Actinogen Medical is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
